Dosage & Administration Drug label Prior authorization Financial assistance

Patient education People also ask

Tegsedi

(inotersen)

Tegsedi 284 MG in 1.5 mL Prefilled Syringe

BLACK BOX WARNING

Dosage & administration

* The recommended dosage is 284 mg administered by subcutaneous injection once weekly.
* Laboratory tests must be measured prior to treatment, continue to be monitored after treatment initiation, and for 8 weeks following discontinuation of treatment, as directed.

drug label

Tegsedi prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Tegsedi prior authorization resources

Most recent Tegsedi prior authorization forms

Verified: Sep 21, 2023Aetna - Tegsedi Prior Authorization Form

Verified: Sep 21, 2023Aetna - Medicare Part B Tegsedi Prior Authorization Form

PDFComplete Letter of Medical Necessity

Learn More

Benefits investigation

PDFPrescription Start Form

Learn More

patient education

Tegsedi patient education

Getting started on Tegsedi

BRAND PAGEInstructions For Use: Polyneuropathy due to Hereditary ATTR

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

BRAND PAGEAbout Tegsedi

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDFTegsedi REMS Wallet Card

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDFPatient Brochure

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Other resources

Learn More

people also ask

Tegsedi FAQs

How is the dosage of Tegsedi?Tegsedi is available in 1 dosages, including 189 mg/ml Prefilled Syringe 1.5 ml

What does Tegsedi treat?Tegsedi treats Familial Amyloid Neuropathies

What is Tegsedi made of?Tegsedi contains inotersen which is a Antisense Oligonucleotide

How Is Tegsedi Administered?Tegsedi is administered as a Injectable

FAQ Data Source